tiprankstipranks

Vuong Trieu Insider Profile

4 Followers
Vuong Trieu, CSO, Director at Sorrento Therapeutics, holds 117.54M shares in Oncotelic Therapeutics (Ticker: OTLC), holds 3.01M shares in Sorrento Therapeutics (Ticker: SRNE). Most recently, Vuong Trieu Bought ― shares of Oncotelic Therapeutics on Jun 24, 2026 for an estimated value of $10.20K.
tipranks
Vuong Trieu

Vuong Trieu
Sorrento Therapeutics (SRNE)
CSO, Director

Ranked #9,681 out of 108,079 Corporate Insiders

Profitable Transactions

53%
8 out of 15 Profitable Transactions

Average Return

+16.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
100.00%
0.00%
A breakdown of Vuong Trieu's holdings

Insider Roles

Oncotelic Therapeutics
(OTLC)
Chairman & CEO, Director, Ten Percent Owner
Sorrento Therapeutics
(SRNE)
CSO, Director
Roles that Vuong Trieu holds in companies

Most Profitable Insider Trade

Stock:
Oncotelic Therapeutics
(OTLC)
Rating:Informative Buy
Date:Nov 26, 2024 - Nov 26, 2025
Return:+212.90%
The most profitable trade made by Vuong Trieu

Vuong Trieu's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Sorrento Therapeutics
Sep 19, 2013
CSO, Director
Uninformative Buy
Oncotelic Therapeutics
Jun 24, 2026
Chairman & CEO, Director, Ten Percent Owner
Informative Buy
10.20K
$5.05M
List of latest transactions for each holding click on a transaction to see Vuong Trieu's performance on stock

Vuong Trieu insider profile FAQ

What is the percentage of profitable transactions made by Vuong Trieu?
The percentage of profitable transactions made by Vuong Trieu is 53%.
    What is the average return per transaction made by Vuong Trieu?
    The average return per transaction made by Vuong Trieu is 16.10%.
      What stocks does Vuong Trieu hold?
      Vuong Trieu holds: SRNE, OTLC stocks.
        What was Vuong Trieu’s latest transaction?
        Vuong Trieu latest transaction was an Informative Buy of $10.20K.
          What was Vuong Trieu's most profitable transaction?
          Vuong Trieu’s most profitable transaction was an Informative Buy of OTLC stock on November 26, 2024. The return on the trade was 212.90%.
            What is Vuong Trieu's role in Sorrento Therapeutics?
            Vuong Trieu's role in Sorrento Therapeutics is CSO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.